EASL Studio S5 E15: EASL Studio’s holiday reflection: A look back to leap forward

EASL Studio S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

EASL Studio S5 E13: Basics in decision-making for liver cancer treatment

EASL Studio S5 E12: PSC and AIH overlap syndrome: does it actually exist?

EASL Studio S5 E11: Statins in cirrhosis: The window hypothesis again, or just a closed window?

EASL Studio S5 E10: Why should diabetologists care about the liver?

EASL Studio S5 E9: Alcohol and the new nomenclature – A game-changer?

EASL Studio S5 E8: JHEP Live: Hepatitis delta’s latest debate: Updates straight from EASL’s slate

EASL Studio S5 E7: Why bother with diet and exercise when an injection will suffice?

EASL Studio S5 E6: YI Choice: When stars fade: The untold story of burnout in academia

EASL Studio S5 E5: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach

EASL Studio S5 E4: PBC: The itch we need to scratch

EASL Studio S5 Special Edition: Highlights from the EASL SLD Summit 2023

EASL Studio S5 E3: Zoonotic Hepatitis E – What’s hot in 2023?

EASL Studio S5 E2: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways

EASL Studio S5 E1: What is really new in the EASL CPG on ACLF?